Influenza Vaccines for the World

2-4 April 2019, Royal College of Physicians of Edinburgh, Edinburgh, Scotland, UK

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Tuesday 2nd April 2019

08.00-09.30
Registration

SESSION 1:
OPENING PLENARY SESSION

Moderator: John Oxford (Blizzard Institute, Queen Mary College London / hVIVO Ltd / Oxford Media & Medicine, London, UK)

09.30-10.00
OPENING KEYNOTE:
‘Replication and pathogenesis of influenza viruses’

Paul Digard (The Roslin Institute, University of Edinburgh, Midlothian, Scotland, UK)

SESSION 2:
INFLUENZA VACCINES & PUBLIC HEALTH CHALLENGES

Moderator: John Oxford (Blizzard Institute, Queen Mary College London / hVIVO Ltd / Oxford Media & Medicine, London, UK)

10.00-10.30
KEYNOTE:
‘WHO strategy for influenza 2019-2030: The “priorities” and most urgent needs to improve seasonal influenza control and pandemic preparedness’

Ann Moen (WHO, Geneva, Switzerland)

10.30-11.00
KEYNOTE:
‘Influenza vaccines: From science into public health policy’

Jon Van Tam (UK Department of Health, London, UK)

11.00-11.20
Coffee Break & Posters Set-Up

SESSION 3:
PANDEMIC VACCINES & PREPAREDNESS

Moderator: Jon Van Tam (UK Department of Health, London, UK)

11.20-11.50
KEYNOTE:
‘The military Final Push 1918: An international attempt to stop a pandemic
at source by vaccination’

John Oxford (Blizzard Institute, Queen Mary College London / hVIVO Ltd / Oxford Media & Medicine, London, UK)

11.50-12.10
‘Influenza Pandemics: Are we ready for the next one?’
Bram Palache (IFPMA/FluPal Consultancy BV, Amstelveen, The Netherlands)

12.10-12.40
‘The future for FLU-v: Efficacy results from a H1N1 challenge study’
Gregory Stoloff and Matthew Memoli (Imutex/SEEK/hVIVO, London, UK)

12.40-13.00
‘Recent meta-analysis study on adjuvanted influenza vaccines’
Bram Palache (IFPMA/FluPal Consultancy BV, Amstelveen, The Netherlands)

13.00-14.00
Lunch Break & Posters

SESSION 4:
INFLUENZA VACCINES DEVELOPMENTS – I

Moderator: Lenny Moise (EpiVax Inc., Providence, Rhode Island, USA)

14.00-14.30
KEYNOTE:
‘Egg-based vs. cell culture-based human influenza vaccines’

John McCauley (Francis Crick Institute, London, UK)

14.30-15.00
‘FLU-v, a broad spectrum influenza vaccine: Cross-reactivity and field results’
Olga Pleguezuelos (Imutex/SEEK/hVIVO, London, UK)

15.00-15.30
‘Getting closer to the market: M-001 universal flu vaccine pivotal phase 3 trial’
Joshua Phillipson and Tammy Ben-Yedidia (BiondVax Pharmaceuticals Ltd., Ness Ziona, Israel)

15.30-15.50
Tea Break & Posters

SESSION 5:
INFLUENZA VACCINES DEVELOPMENTS – II
ANTIGEN DESIGN & CHARACTERIZATION

Moderator: Rob-Lambkin Williams (hVIVO Services Ltd, London, UK)

15.50-16.20
KEYNOTE:
‘Recent progress in novel, cross-reactive and universal influenza vaccines’

Sean Tucker (VAXART Inc, South San Francisco, California, USA)

16.20-16.40
‘Next-generation broadly reactive influenza vaccines’
James D. Allen (University of Georgia, Athens, Georgia, USA)

16.40-17.00
‘Development of a T cell-based universal influenza vaccine’
Chris Ellis (Vaccitech Ltd., Oxford, UK)

17.00-17.20
‘Intranasal M2SR (M2-deficient Single Replication) influenza vaccine induced protection against challenge with a substantially drifted H3N2 virus in a Phase 2 study’
Joseph Eiden1, Bram Volckaert2, Oleg Rudenko2, Ruth Ellis3, Roger Aitchison4, Renee Herber1, Robert Belshe5, Harry Greenberg6, Kathleen Coelingh7, Yoshihiro Kawaoka8, Gabriele Neumann8 and Pamuk Bilsel1 (1 FluGen, Inc., Madison, Wisconsin, USA; 2 SGS Life Sciences, Antwerp, Belgium; 3 Biologics Consulting, Alexandria, Virginia, USA; 4 North Rim Consulting, Denver, Colorado, USA; 5 Saint Louis University, St. Louis, Missouri, USA; 6 Stanford University, Stanford, California, USA; 7 St. Helena, California, USA; 8 Influenza Research Institute, University of Wisconsin, Madison, Wisconsin, USA)

 

IVW 2019 Delegates

Login details will be supplied after you have registered for the event.


IVW 2019 Sponsors

  • Vaxxas
  • SPbSRIVS
  • hVIVO
  • Vaxart
  • Sanofi Pasteur
  • Vismederi
  • NanoPass
  • APACI
  • Medicago
  • Izon Science
  • isirv
  • FluConsult
  • Novavax
  • InDevR
  • MedImmune
  • Eurocine Vaccines
  • Janssen
  • Inovio Pharmaceuticals
  • BiondVax

IVW 2019 Downloads

IVW 2019 Leaflet

IVW 2019 Mailing List

Name
E-mail Address
What is 3+2-1?